HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of angiotensin-converting enzyme inhibitors on phenylephrine responsiveness in patients with valvular heart disease.

Abstract
We studied patients with valvular heart disease to investigate whether chronic preoperative treatment with angiotensin-converting enzyme (ACE) inhibitors modulates the effect of phenylephrine (PE) on anaesthesia-induced hypotension. Sixty-five patients were enrolled in the study and hypotension developed after anaesthesia in 36 (18 in the control group and 18 in the ACE inhibitor group). These patients received PE infusions, which were increased in a stepwise fashion at 10-min intervals. Increased mean arterial pressure due to PE infusion was significant only in the control group. There was no significant difference in pressor response or change in haemodynamic variables with PE infusion between the two groups. Treatment with ACE inhibitors did not increase the incidence of hypotensive episodes or significantly modify pressor response after anaesthesia in patients with valvular heart disease.
AuthorsH J Kwak, Y L Kwak, Y J Oh, Y H Shim, S H Kim, Y W Hong
JournalThe Journal of international medical research (J Int Med Res) 2005 Mar-Apr Vol. 33 Issue 2 Pg. 150-9 ISSN: 0300-0605 [Print] England
PMID15790126 (Publication Type: Journal Article)
Chemical References
  • Adjuvants, Anesthesia
  • Androstanols
  • Angiotensin-Converting Enzyme Inhibitors
  • Cardiotonic Agents
  • Neuromuscular Nondepolarizing Agents
  • Phenylephrine
  • Sufentanil
  • Midazolam
  • Rocuronium
Topics
  • Adjuvants, Anesthesia (pharmacology)
  • Adult
  • Aged
  • Androstanols (pharmacology)
  • Angiotensin-Converting Enzyme Inhibitors (pharmacology)
  • Cardiotonic Agents (pharmacology)
  • Female
  • Heart Diseases (surgery)
  • Heart Valves (pathology)
  • Humans
  • Hypotension (chemically induced)
  • Male
  • Midazolam (pharmacology)
  • Middle Aged
  • Neuromuscular Nondepolarizing Agents (pharmacology)
  • Phenylephrine (metabolism)
  • Rocuronium
  • Sufentanil (pharmacology)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: